Vestiage, Inc. Reveals Two New Products
April 02 2014 - 12:00AM
Business Wire
Ingredients to Address Top Male and Female
Concerns
Vestiage™, Inc. (Pink Sheets:VEST), the emerging leader in
healthy aging, announced today that it has completed R&D for
two new products that it intends to launch in upcoming quarters.
Utilizing the latest scientific advances and patented ingredients,
substantiated with clinical studies and results, Vestiage, Inc. has
a pipeline of new products to address the most in-demand issues for
both men and women.
“We’re excited to be launching the latest addition to our
RegiMEN™ line very soon,” said Scott Kimball, CEO of Vestiage, Inc.
“We believe that RegiMEN TITANIUM™ Testosterone Support will be the
only product of its kind on the market, containing four clinically
tested, patented ingredients in an elegant formulation. This is the
next generation of testosterone support for the industry. We don’t
know of any natural product that will be able to match the results
we expect this to deliver.” Retail price points for RegiMEN
TITANIUM™ are expected to range between $129.99 and $149.99.
The second new product from Vestiage scheduled for launch is
INTIMACY for Women™ by Monterey Bay Nutraceuticals™. “The
formulation naturally addresses some of the largest concerns of
many women in one simple product. There are many items currently on
the market that address vitality and energy for men, but very few
products exist for women. We’re changing that,” said Kimball.
INTIMACY for Women™ contains a patented natural ingredient with
clinically tested results. The randomized, placebo-controlled,
double-blind study involved 80 women with low sex drives who
claimed to be in stable relationships. The results of the study,
which focused on sexual vitality and desire, showed subjects
reporting positive changes in both physiological and psychosocial
aspects of sexual function – including arousal, orgasm, drive,
sexual cognition, and a reduction in fatigue.
Both products are expected to be available online at the
company’s websites and landing pages, as well as in select retail
stores. Initially, RegiMEN TITANIUM™ is anticipated to be available
exclusively with a yet unannounced major retailer for a limited
period of time. INTIMACY for Women™ will be used as the leading
product when Vestiage, Inc. launches its full Monterey Bay
Nutraceuticals™ line through retail channels. Both new products
will be available through the company’s monthly continuity program,
which allows customers to purchase products conveniently on an
automated basis.
Kimball added, “Our goal has always been to bring natural, safe,
and innovative products to market while addressing the largest
in-demand issues and concerns of astute, health-oriented, active
men and women. We are achieving that goal and taking a major step
forward with these two new products. With time, we feel we can
reach our goal of one million men and one million women
participating in our monthly continuity program, while nurturing
significant presence within the major drug, grocery and specialty
retailers in the USA.”
About Vestiage™
Vestiage™ (Pink Sheets:VEST) is a publicly traded emerging
leader in healthy aging. The company specializes in bringing
science-based products to the healthy-aging premium consumer
through multiple channels utilizing a network of key partners that
integrate production, fulfillment, customer service, advertising,
sales, media, marketing, distribution, and new product development.
Vestiage™ is focused on the use of marine/ocean and cutting-edge,
botanically based science and patented ingredients to produce
highly potent, elegantly formulated products with clinically proven
ingredients. Using high potency and novel ingredient combinations,
Vestiage™ creates and distributes multifunctional nutraceuticals
such as RegiMEN™ for men (www.BuyRegimen.com) and Monterey Bay
Nutraceuticals™ for women. (www.MontereyBayNutra.com). Vestiage™
brands address the top “in-demand” healthy-aging concerns of men
and women. Vestiage™ research is focused on longevity and human
performance science that covers both the cognitive and physical
realms. To learn more, visit the company website,
www.vestiageinc.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
with respect to our financial condition, results of operations and
business. These forward-looking statements can be identified by the
use of terms such as "believe," "expects," "plan," "intend," "may,"
"will," "should," "can," or "anticipates," or the negative thereof,
or variations thereon, or comparable terminology, or by discussions
of strategy. These statements involve known and unknown risks,
uncertainties and other factors that may cause industry trends or
our actual results to be materially different from any future
results expressed or implied by these statements. Important factors
that may cause our results to differ from these forward-looking
statements include, but are not limited to: (i) changes in or new
government regulations or increased enforcement of the same, (ii)
unavailability of desirable acquisitions or inability to complete
them, (iii) increased costs, including from increased raw material
or energy prices, (iv) changes in general worldwide economic or
political conditions, (v) adverse publicity or negative consumer
perception regarding nutritional supplements, anti-aging or stem
cell facial care products or stem cell technology in general, (vi)
issues with obtaining raw materials of adequate quality or
quantity, (vii) litigation and claims, including product liability,
intellectual property and other types, (viii) disruptions from or
following acquisitions including the loss of customers, (ix)
increased competition, (x) slow or negative growth in the
anti-aging or cosmetics, beauty, or nutritional supplement industry
or the healthy foods or anti-aging channel, (xi) the loss of key
personnel or the inability to manage our operations efficiently,
(xii) problems with information management systems, manufacturing
efficiencies and operations, (xiii) insurance coverage issues,
(xiv) the volatility of the stock market generally and of our stock
specifically, (xv) increases in the cost of borrowings or
unavailability of additional debt or equity capital, or both, or
fluctuations in foreign currencies, and (xvi) interruption of
business or negative impact on sales and earnings due to acts of
God, acts of war, terrorism, bio-terrorism, civil unrest and other
factors outside of our control.
Vestiage, Inc.Scott Kimball,
CEOir@vestiageinc.com949-258-4404
Vestiage (PK) (USOTC:VEST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vestiage (PK) (USOTC:VEST)
Historical Stock Chart
From Apr 2023 to Apr 2024